Navigation Links
P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth
Date:10/29/2008

et earnings increased two percent for the quarter to $658 million as sales growth, lower overhead spending as a percent of net sales and divestiture gains were mostly offset by higher commodity costs.

-- Snacks, Coffee and Pet Care net sales increased nine percent to $1.2 billion for the quarter on two percent volume growth. Pricing contributed seven percent to net sales due to multiple price increases in Coffee and Pet Care, and favorable foreign exchange added two percent to net sales. These were partially offset by a negative two percent product mix impact from the disproportionate growth of Snacks, which has lower selling prices than the segment average. Snacks volume increased mid-single digits due to double- digit growth in North America behind strong base business growth of Pringles and continued growth from Pringles Extreme Flavors and Stix initiatives. Coffee sales grew double digits due to the combination of volume growth and pricing. Coffee volume grew low-single digits behind the Folgers Roast & Ground restage and continued expansion of the Dunkin Donuts(R) line. Pet Care sales increased high-single digits due to the impact of pricing. Pet Care volume declined low-single digits as growth of Iams was more than offset by a decline of Eukanuba. Net earnings increased six percent to $120 million for the quarter. Importantly, earnings growth was reduced by over twenty percent due to Katrina insurance claim receipts in the base. Net earnings increased behind sales growth and lower SG&A expenses as a percentage of net sales, which were partially offset by higher commodity costs.

Household Care GBU

-- Fabric Care and Home Care net sales increased 10 percent during the quarter to $6.5 billion. Volume grew two percent behind mid-single digit growth of Fabric Care from the launch of Tide and Downy Total Care, trade inventory increases prior to September price increases in North America and innovation in developing regions. Volume in Home Care d
'/>"/>

SOURCE The Procter & Gamble Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Cardinal Health Reports First Quarter Results
2. uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series
3. STAAR Surgical Reports 33% Third Quarter Revenue Growth
4. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
5. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
6. LCA-Vision Reports Third Quarter 2008 Financial Results
7. Universal Health Services, Inc. Reports 2008 Third Quarter Results
8. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
9. Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009
10. WellPoint Reports Third Quarter 2008 Results
11. Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/9/2009).../PRNewswire-FirstCall/ - Hard to Treat Diseases (H...ntly completed a merger with Slavica Bio Chem (For... billion shares to pay for the Slavica merger and ...or Slavica is 300 million non-dilatable restricted...lved in Belgrade Serbia research. Key medical cons...
(Date:1/8/2009)...ire/ -- New York City Mayor Michael R. Bloomberg d..." and presented a proclamation to Ilchi Lee, presi...iation) and developer of Brain Education, a revolu...alth, well-being, and mental ability for all ages....ding the power of individuals to change themselves...
(Date:1/8/2009)...e/ -- A study released this week showing that a gr...ple chronic diseases shines a much-needed spotligh... to one that focuses on primary and secondary prev... leader in disease prevention. , , (Logo: h...9LOGO ) , , The study, conducted by Social &a...
(Date:1/8/2009)...enator Daschle at his confirmation hearing to be t... , , WASHINGTON, Jan. 8 /PRNewswire-USNewswire/...member Senator Tom Daschle, nominee for Department...duced by fellow BPC founder and friend Senator Bob...ng was convened by the Senate Health, Education, L...
Breaking Medicine News(10 mins):Health News:Hard To Treat Diseases (HTDS) Recapitalization 2Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4
...gic reaction caused to many human beings. A new Ma...// allergic contact dermatitis. The exact definiti...ammation resulting in swollen, reddened and itchy ...rgen. The ten allergens identified by the mayo st...
...y foods seemed to score less in nutrition value be...nutrients, // like iron and protein. Sales of orga...four babies are growing up on daily helpings of th... appropriate labeling of baby food , came into for...
...a sudden emotional stress could weaken the heart. ...failure// in romance are said to be the triggering...archers at Johns Hopkins University found that sho...that mimic a serious heart attack causing severe h...
...nt officials that the much dreaded bird flu virus ... in UK//. The feral birds have the potential of po...urban areas, as they are susceptible to infection ...exact mechanism of how pigeons contract the infect...
Other Medicine News:
(Date:1/9/2009).../ -- ESBATech AG, a leading developer of antibody ...ion of the Phase I/IIa clinical development of its...arthritis (OA). This double-blind, randomized, pla...gned to investigate the safety, tolerability and e...ntra-articular administration to patients with sev...
(Date:1/8/2009)...wire-FirstCall/ -- , - ThromboGenics, Lead ...acular Adhesion in the US and Europe , Thro...logy company,focused on innovative treatments for...ces today that it has started the Phase III clinic...reatment of back of the eye disease, the,final st...
(Date:1/8/2009)...econd indication with clinical-stage, systemically...ONT, Calif., Jan. 8 Quark Pharmace...company discovering and developing novel RNA inter... that it has initiated patient dosing in its Phase...dministered siRNA drug candidate QPI-1002 (previou...
(Date:1/8/2009)...te Novel Gene Expression Biomarkers Involved in Wo...rm , , FREMONT, Calif., Jan. 8 /PRNewswire-Firs...Board: WGBS), a leading developer of state-of-the-...stem cell research systems, today announced the si...sity of Texas Southwestern Medical Center for the...
Breaking Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Media Affects Public Perception of Infectious Diseases 28442 1Media Affects Public Perception of Infectious Diseases 28442 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 1Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 2Senator Obama Explains His Health Care Plan to SpineUniverse com 28439 3Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 1Natural Hormone Balance 3A Gaining Ground in the Fight Against Breast Cancer 28436 2If metastasectomy should be performed before other treatments 28433 1If metastasectomy should be performed before other treatments 28433 2
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
...tive lens delivering magnification of 2.0x, 2.5x a...f use. Movement whilst maintaining focal clarity i...The ultra lightweight aluminum bar and individual ...he mounted loupes and optimal focal alignment, eli...
Utilized for capsulotomies, nucleus dislocating, and other intraocular applications. Formed (bent) cystitomes are angled to conform to the convexity of the lens, providing easier access to the anteri
23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 30 degree shaft 8 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Dual hub construction. Polished finish. Ov
Medicine Products: